Explore more publications!

Press Releases

Danish Entrepreneur Shares 33-Year China Journey at Jiaxing Opening-Up Symposium
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
High Protein Powders Market Size to Worth USD 50.43 Billion by 2035, Driven by Clean-Label Nutrition, AI Formulation, and Plant-Based Demand
Frozen Yogurt Market Set to Reach USD 11.53 Billion by 2035, Driven by Health Trends and Flavor Innovation
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris
Fruit Snacks Market Size to Worth 48.60 billion by 2035, Fueled by Health, Innovation, and AI-Driven Trends
Missouri Farm Bureau partners with Rezilient Health to provide comprehensive primary care benefit to employees
Medical Device Testing Market Expected to Surpass USD 24.32 Billion by 2034
WakeMed becomes one of the first U.S. health systems to integrate Rezilient CloudClinics
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Noom Enters Longevity Health Space with Proactive Health Microdose GLP-1Rx Program Designed to Help Millions Address the Biomarkers Most Linked to Future Disease
IIP Denmark (IIP) Selects Harvest by Dasseti to Elevate ESG and Investment Data Management
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035
Drug Trials Snapshots: LYNKUET

Drug Trials Snapshots: LYNKUET

Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions